COVID 19 / Influenza virus A and B - panel - direct diagnosis - PCR
Back to main menuEurofins Biomnis code
COVGR
Synonyms
- A and B Influenza
- SARS-CoV-2
- COVID
- A and B Influenza
- COVID-19
Clinic significance
Respiratory viral illnesses in winter have an unspecific symptomatology, making it impossible to identify a particular viral agent.
Influenza and SARS-CoV-2 infections can be potentially serious. Simultaneous testing for the viruses responsible for influenza and COVID-19 infection can enable patients to be managed appropriately, particularly when they are hospitalised or in social health-care institutions.
PCR includes simultaneous testing for influenza A and B viruses and COVID-19 infection, and is performed on nasopharyngeal swabs.
Prenalytics
- 1 mL
- Nasopharyngeal swab
- Refrigerated
Further information
- The use of the S14UK transport bag is Mandatory.
- .
- Swab samples require the use of a transport medium (viral) supplied in kit K1.
Specific equipment available
K1: Virus screening kit by culture or PCR
Documents to download
Methodology
RT - PCR in real time
Turnaround time
2 days
Pathologist(s) in charge
Biomnis Lyon
Specialty
Infectious
Contact(s)
Dr Anaïs SOARES
Dr Marie HERVO
Dr Secrétariat médical spécialisé Eurofins Biomnis
Dr Thomas BLANCHOT
Dr Marie HERVO
Dr Secrétariat médical spécialisé Eurofins Biomnis
Dr Thomas BLANCHOT
E-mail(s)
Phone(s)
+334 72 80 73 99
+334 72 80 73 99
+334 72 80 73 99
+334 72 80 73 99
+334 72 80 73 99
+334 72 80 73 99
+334 72 80 73 99
